Ladang Aurélie

Ladang, A., KOVACS, S., Lengele, L., Locquet, M., Beaudart, C., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (October 2023). Neurofilament-light chains (NF-L), a biomarker of neuronal damage, is increased in patients with severe sarcopenia: results of the SarcoPhAge study. Aging Clinical and Experimental Research, 35 (10), 2029 - 2037. doi:10.1007/s40520-023-02521-9

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (11 September 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. HIV Cure Symposium 2023, Gand, Belgium.

Ladang, A., Beaudart, C., Reginster, J.-Y., Al-Daghri, N., Bruyère, O., Burlet, N., Cesari, M., Cherubini, A., da Silva, M. C., Cooper, C., Cruz-Jentoft, A. J., Landi, F., Laslop, A., Maggi, S., Mobasheri, A., Ormarsdottir, S., Radermecker, R., Visser, M., Yerro, M. C. P., ... Cavalier, E. (September 2023). Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging. Calcified Tissue International, 113 (3), 357 - 358. doi:10.1007/s00223-023-01114-y

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (21 February 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Conference on Retroviruses and Opportunistic Infection (CROI 2023), Seattle, United States.

LADANG, A., Rauch, F., Delvin, E., & Cavalier, E. (February 2023). Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation. Calcified Tissue International, 112 (2), 218-232. doi:10.1007/s00223-022-00964-2

Ladang, A., Beaudart, C., Reginster, J.-Y., Al-Daghri, N., Bruyère, O., Burlet, N., Cesari, M., Cherubini, A., da Silva, M. C., Cooper, C., Cruz-Jentoft, A. J., Landi, F., Laslop, A., Maggi, S., Mobasheri, A., Ormarsdottir, S., Radermecker, R., Visser, M., Yerro, M. C. P., ... Cavalier, E. (12 January 2023). Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging. Calcified Tissue International, online. doi:10.1007/s00223-022-01054-z

Le Goff, C., Berisha, T., de Marchin, J., Ladang, A., VRANKEN, L., & Cavalier, E. (2023). Case report : false positive result of ultrasensitive troponin I in Emergency department [Poster presentation]. Euromedlab 2023, Rome, Italy.

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (23 November 2022). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Belgium Research on AIDS and HIV Consortium (BREACH 2022), Bruxelles, Belgium.

Dufour, P., Grifnee, E., BREVERS, E., Paquot, N., Le Goff, C., Cavalier, E., & Ladang, A. (18 November 2022). LABORATORY EXPLORATION OF A VERY HIGH LEVEL OF INSULIN MEASURED IN A LONG-STANDING TYPE 1 DIABETIC PATIENT [Poster presentation]. 2022 Annual RBSLM Meeting.

LE GOFF, C., LADANG, A., GOTHOT, A., & CAVALIER, E. (May 2022). Les marqueurs biologiques de l’inflammation : faisons le point. Revue Médicale de Liège, 77 (5-6), 258-264.

LADANG, A., KOVACS, S., Lengele, L., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (2022). Neurofilament-light chains (NF-L), a biomarker of neuronal damage, is increased in sarcopenic patients: results of the sarcophage study. Osteoporosis International, 32 (Suppl 1), 53.

Ladang, A., Kovacs, S., Lengele, L., Locquet, M., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (2022). Neurofilament light chain concentration in an aging population. Aging Clinical and Experimental Research, 34 (2), 331-339. doi:10.1007/s40520-021-02054-z

LADANG, A., Rigaud, L., Sqalli, G., & Cavalier, E. (July 2021). Effects of various pre-analytical conditions on blood-based biomarkers of Alzheimer's disease. Clinical Chemistry and Laboratory Medicine, 59 (12), 435-e437. doi:10.1515/cclm-2021-0637

Sqalli, G., Cavalier, E., & LADANG, A. (May 2021). Dosage au laboratoire de chimie clinique des biomarqueurs circulants oncologiques : limites et perspectives. Revue Médicale de Liège, 76 (5-6), 352-357.

Schoneveld, L., LADANG, A., HENKET, M., Frix, A.-N., Cavalier, E., Guiot, J., MALAISE, O. (Other coll.), & LAMBERMONT, B. (Other coll.). (February 2021). YKL-40 as a new promising prognostic marker of severity in COVID infection. Critical Care, 25 (1), 66. doi:10.1186/s13054-020-03383-7

Schoneveld, L., CAVALIER, E., VALDES SOCIN, H. G., GRANDFILS, S., & LADANG, A. (January 2021). Étude rétrospective du bilan thyroïdien chez les femmes enceintes : définition des valeurs de référence de TSH et FT4. Revue Médicale de Liège, 46 (1), 44-49.

Frix, A.-N., Schoneveld, L., LADANG, A., HENKET, M., DUYSINX, B., VAILLANT, F., Misset, B., Moutschen, M., Louis, R., Cavalier, E., & Guiot, J. (November 2020). Could KL-6 levels in COVID-19 help to predict lung disease? Respiratory Research, 21 (309). doi:10.1186/s12931-020-01560-4

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., Le Goff, C., & Cavalier, E. (2020). Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers. Acta Clinica Belgica, 1-6. doi:10.1080/17843286.2020.1769285

Cavalier, E., Huyghebaert, L., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., VRANKEN, L., PEETERS, S., Le Goff, C., & LADANG, A. (2020). Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clinical Chemistry and Laboratory Medicine, 58 (2), 197-201. doi:10.1515/cclm-2019-0996

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (2020). Evaluation of a panel of microRNAs that predicts fragility fracture risk: a pilot study. Calcified Tissue International, 106 (3), 239-247. doi:10.1007/s00223-019-00628-8

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (July 2019). Fragility fracture risk prediction in elderly people based on a micro RNA panel. Osteoporosis International, 30 (S2), 299-S300.

LADANG, A., BERTHOLET, C., VRANKEN, L., & CAVALIER, E. (May 2019). GLOBAL STRATEGY OF IMPLEMENTATION OF CALIPER PEDIATRIC REFERENCE VALUES IN A BELGIAN INSTITUTE [Poster presentation]. Euromedlab 2019.

LADANG, A., Seynaeve, Y., & CAVALIER, E. (May 2019). DIAGNOSTIC POTENTIAL OF MIRNAS IN PARATHYROID CARCINOMAS [Poster presentation]. Euromedlab 2019.

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). 24,25(OH)2D AS A MARKER OF VITAMIN D DEFICIENCY IN CHILDREN: A RETROSPECTIVE [Poster presentation]. Euromedlab 2019.

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). EVALUATION OF PARATHORMONE AND 25-HYDROXYVITAMIN D STATUS IN A LARGE [Poster presentation]. Euromedlab 2019.

LADANG, A., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., & CAVALIER, E. (May 2019). PEDIATRIC REFERENCE INTERVALS FOR BONE ALKALINE PHOSPHATASE ON LIAISON° XL [Poster presentation]. Euromedlab 2019.

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., Bruyère, O., & CAVALIER, E. (April 2019). Risk-fracture prediction in elderly people based on a microRNA panel [Poster presentation]. IOF-WHO osteoporosis congress.

LADANG, A., VRANKEN, L., & CAVALIER, E. (November 2017). Pediatric reference intervals: Retrospective study for 8 common chemistry parameters on Cobas c6000 analyzer (Roche°) [Poster presentation]. meeting annuel RBSLM.

LADANG, A., SIMUL, M., SOMJA, J., FOGUENNE, J., GOTHOT, A., KEUTGENS, A., & TASSIN, F. (February 2017). Richter syndrome with plasmablastic lymphoma [Paper presentation]. 32nd General Annual Meeting 2017, Bruxelles, Belgium.

LADANG, A., SIMUL, M., SOMJA, J., FOGUENNE, J., GOTHOT, A., KEUTGENS, A., & TASSIN, F. (February 2017). Unconventional richter syndrome with plasmablastic transformation [Poster presentation]. 32nd General Annual Meeting 2017, Bruxelles, Belgium.

LADANG, A., VRANKEN, L., LUYCKX, F., LEBRETHON, M.-C., & CAVALIER, E. (2017). Etude rétrospective du bilan thyroïdien: définition de valeurs de référence pédiatriques. Revue Médicale de Liège.

LADANG, A., VRANKEN, L., & CAVALIER, E. (October 2016). Unexpected high levels of Cobalamin (Vitamin B12): Numerous interferences are decreased by PEG treatment [Poster presentation]. Congrès de la société belge de médecine de laboratoire.

Delaunay, S., Rapino, F., Zhou, Z., Shostak, K., LADANG, A., Chariot, A., & Close, P. (25 January 2016). tRNA modification: Elogator promotes metastasis in breast cancer [Paper presentation]. GIGA-DAY 2016, Liège, Belgium.

Göktuna, S., Shostak, K., Chau, T.-L., Heukamp, L., Hennuy, B., Duong, H. Q., LADANG, A., Close, P., Klevernic, I., Olivier, F., Florin, A., Ehx, G., Baron, F., Vandereyken, M., Rahmouni, S., Vereecke, L., van Loo, G., Büttner, R., Greten, F., & Chariot, A. (2016). The Prosurvival IKK-Related Kinase IKK« Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine. Cancer Research, 76, 2587-99. doi:10.1158/0008-5472.CAN-15-1473

LADANG, A.* , Rapino, F.* , Heukamp, L., Tharun, L., Shostak, K., Hermand, D., Delaunay, S., Klevernic, I., Jiang, Z., Jacques, N., Jamart, D., Migeot, V., Florin, A., Göktuna, S., Malgrange, B., Samson, O., Nguyen, L., Buettner, R., Close, P., & Chariot, A. (16 November 2015). Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine. Journal of Experimental Medicine, 212 (12), 2057-75. doi:10.1084/jem.20142288

Delaunay, S., Rapino, F., Zhou, Z., LADANG, A., Shostak, K., Chariot, A., & Close, P. (09 March 2015). Elongator: mcm5s2 modification fosters breast cancer metastasis [Paper presentation]. MRC toxicology meeting, Leicester, United Kingdom.

Delaunay, S., Rapino, F., Heukamp, L., LADANG, A., Jiang, Z., Nguyen, L., Buettner, R., Chariot, A., & Close, P. (March 2015). Elongator promotes breast cancer metastasis [Poster presentation]. EMBO meeting, Frontiers in stem cells, Heidelberg, Germany.

Delaunay, S., Heukamp, L., Zhou, Z., Shostak, K., LADANG, A., Jiang, Z., Nguyen, L., Chariot, A., & Close, P. (08 May 2014). Elongator drives breast cancer initiation and metastasis formation [Poster presentation]. ENBDC meeting 2014, Weggis, Switzerland.

Ladang, A. (2014). Insights into the role of Elp3 in Wnt-driven tumor initiation and regeneration [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/169298

Shostak, K., Zhang, X., Hubert, P., Göktuna, S., Jiang, Z., Klevernic, I., Hildebrand, J., Roncarati, P., Hennuy, B., Ladang, A., SOMJA, J., Gothot, A., Close, P., Delvenne, P., & Chariot, A. (2014). NF-kappaB-induced KIAA1199 promotes survival through EGFR signalling. Nature Communications, 5, 5232. doi:10.1038/ncomms6232

Ladang, A., Heukamp, L., Buettner, R., Jiang, Z., Jamart, D., Close, P., & Chariot, A. (18 September 2013). Elp3 is required for initiation of colon cancer [Poster presentation]. Experimental models of human diseases.

Close, P., Gillard, M., Ladang, A., Jiang, Z., Papuga, J., Hawkes, N., Nguyen, L., CHAPELLE, J.-P., Bouillenne, F., Svejstrup, J., Fillet, M., & Chariot, A. (2012). DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity and migration of melanoma cells as subunits of Elongator. Journal of Biological Chemistry. doi:10.1074/jbc.M112.402727

Close, P., Gillard, M., Ladang, A., Jiang, Z., Fillet, M., & Chariot, A. (12 March 2011). DERP6 and C3orf75 regulate the invasive potential of melanoma cells as subunits of the elongator complex [Poster presentation]. Stem Cells, Cancer and Metastasis, United States.

Close, P., Creppe, C., Gillard, M., LADANG, A., Chapelle, J.-P., Nguyen, L., & Chariot, A. (April 2010). The emerging role of lysine acetylation of non-nuclear proteins. Cellular and Molecular Life Sciences, 67 (8), 1255-1264. doi:10.1007/s00018-009-0252-7